Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes

Published:2018-09 Issue:9 Volume:23 Page:1635-1643
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Tripathi Manish K.,Doxtater Kyle,Keramatnia Fatemeh,Zacheaus Chidi,Yallapu Murali M.,Jaggi Meena,Chauhan Subhash C.

Funder

National Institutes of Health Research Project Grant Program

UTHSC-College of Pharmacy-Dean’s Seed Grant

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference64 articles.

1. An integrated encyclopedia of DNA elements in the human genome;ENCODE Project Consortium;Nature,2012

2. Panel of seven long noncoding RNA as a candidate prognostic biomarker for ovarian cancer;Zhan;Onco Targets Ther.,2017

3. Long noncoding RNA expression signature to predict platinum-based chemotherapeutic sensitivity of ovarian cancer patients;Liu;Sci. Rep.,2017

4. Identification of a six-lncRNA signature associated with recurrence of ovarian cancer;Yang;Sci. Rep.,2017

5. FIGO’s staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication;Prat;J. Gynecol. Oncol.,2015

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosome-Based Smart Drug Delivery for Cancer Treatment;Pharmaceutical Science;2024-08-21

2. Long non‐coding RNA TPT1‐AS1 inhibits ferroptosis in ovarian cancer by regulating GPX4 via CREB1 regulation;American Journal of Reproductive Immunology;2024-08

3. Management of triple-negative breast cancer by natural compounds through different mechanistic pathways;Frontiers in Genetics;2024-07-26

4. Long Non-Coding RNAs: New Insights in Neurodegenerative Diseases;International Journal of Molecular Sciences;2024-02-14

5. Long noncoding RNA LINC00885 upregulates NCK1 to promote cell viability and migration of triple-negative breast cancer cells through sponging miR-654-3p;Cancer Biomarkers;2024-01-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3